Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma

NCT07050186 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Northwestern University

Collaborators